Ashland Inc. (ASH)
Market Cap | 3.07B |
Revenue (ttm) | 2.05B |
Net Income (ttm) | -22.00M |
Shares Out | 47.18M |
EPS (ttm) | -0.46 |
PE Ratio | n/a |
Forward PE | 13.54 |
Dividend | $1.62 (2.49%) |
Ex-Dividend Date | Feb 28, 2025 |
Volume | 612,134 |
Open | 65.81 |
Previous Close | 65.43 |
Day's Range | 64.70 - 66.34 |
52-Week Range | 60.60 - 102.50 |
Beta | 0.86 |
Analysts | Buy |
Price Target | 93.50 (+43.89%) |
Earnings Date | Jan 28, 2025 |
About ASH
Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives. Its Personal Care segment provides a range of natural, n... [Read more]
Financial Performance
In 2024, Ashland's revenue was $2.11 billion, a decrease of -3.56% compared to the previous year's $2.19 billion. Earnings were $169.00 million, a decrease of -5.06%.
Financial StatementsAnalyst Forecast
According to 7 analysts, the average rating for ASH stock is "Buy." The 12-month stock price forecast is $93.5, which is an increase of 43.89% from the latest price.
News

Ashland Inc. (ASH) Q1 2025 Earnings Call Transcript
Ashland Inc. (NYSE:ASH) Q1 2025 Earnings Conference Call January 29, 2025 9:00 AM ET Company Participants William Whitaker - VP, Finance and Director, IR Guillermo Novo - Chair and CEO Kevin Willis -...

Ashland reports financial results for first quarter fiscal 20251, reiterates outlook for full-year fiscal 2025
WILMINGTON, Del., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced financial results1 for the first quarter of fiscal year 2025, which ended December 31, 2024, and issued its...

Forget The S&P 500 - 3 Small Dividend Stocks At Big Discounts
President Trump inherits a historically expensive stock market, with the Shiller P/E ratio indicating potentially subdued long-term returns for the S&P 500. Despite high valuations, opportunities exis...

Ashland board authorizes quarterly dividend
WILMINGTON, Del., Jan. 20, 2025 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE: ASH) has declared a quarterly cash dividend of $0.405 cents per share on the company's common stock. T...

Ashland sets date for first-quarter fiscal 2025 earnings release and conference call webcast
WILMINGTON, Del., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its first-quarter fiscal 2025 earnings release at approximately 5 p.m. ET on Tuesday, Januar...

Ashland signs definitive agreement to sell Avoca business to Mane
Wilmington, Del., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) announced today that it has signed a definitive agreement to sell its Avoca business to Mane. The transaction is expected t...

Ashland: A Stable Stock Trading At 50% Discount To Its Intrinsic Value
Ashland Inc. (NYSE: ASH) offers a promising upside of 58.3% with a target price of $125.72, driven by its strong financial fundamentals and growth potential in biotechnology. The company is well-diver...

Ashland rings opening bell at NYSE recognizes 100-year anniversary
Wilmington, Del., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Participating in a tradition that has evolved since 1792, today, employees from Ashland Inc. (NYSE: ASH) gathered on the floor of the New York Stock...

Ashland celebrates solvers, recognizes 100 years of innovation by planting trees to restore local ecosystems and support sustainable sourcing
Wilmington, Del., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH), the global additives and specialty ingredients company today announced a strategic partnership with the Arbor Day Foundati...

Ashland Inc. (ASH) Q4 2024 Earnings Call Transcript
Ashland Inc. (NYSE:ASH) Q4 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants William Whitaker - VP, Finance and Director, IR Guillermo Novo - Chair and CEO Kevin Willis -...

Top 3 Materials Stocks That Are Preparing To Pump In Q4
The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.

Ashland to host live 2024 strategy update event for analysts and investors
WILMINGTON, Del., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) will host a strategy update event for analysts and investors on Tuesday, December 10, 2024, in New York City. The company w...

Ashland sets date for fourth-quarter fiscal 2024 earnings release and conference call webcast
WILMINGTON, Del., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its fourth-quarter fiscal 2024 earnings release at approximately 5 p.m. ET on Wednesday, Nov...

D.A. Davidson Acts as Exclusive Financial Advisor to Turnspire Capital Partners for Debt Financing in Support of Turnspire's Acquisition of Pharmachem
NEW YORK--(BUSINESS WIRE)--D.A. Davidson & Co. announced today that it served as exclusive financial advisor to Turnspire Capital Partners LLC (“Turnspire”) on an asset-backed credit facility to finan...

Ashland completes sale of nutraceuticals business
WILMINGTON, Del., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced it has completed the sale of its nutraceuticals business to an affiliate of Turnspire Capital Partners LLC...

Pharmachem Innovations Launches as a Leading Independent Provider of Nutraceuticals Products and Solutions
KEARNY, N.J.--(BUSINESS WIRE)--Pharmachem Innovations, LLC (“Pharmachem” or the “Company”), a leading provider of nutraceuticals products and solutions, today announced its launch as an independent co...

Turnspire Capital Partners Completes Acquisition of Pharmachem from Ashland
NEW YORK--(BUSINESS WIRE)--Turnspire Capital Partners LLC (“Turnspire”) announced today that an affiliate has completed the acquisition of Pharmachem Innovations, LLC (“Pharmachem” or the “Company”), ...

Ashland Inc. (ASH) Q3 2024 Earnings Call Transcript
Ashland Inc. (NYSE:ASH) Q3 2024 Earnings Conference Call August 7, 2024 10:00 AM ET Company Participants William Whitaker - Vice President-Finance and Director-Investor Relations Guillermo Novo - Cha...

Ashland reports financial results1 for third quarter fiscal 2024, issues outlook for fourth quarter and full-year fiscal 2024
WILMINGTON, Del., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced financial results1 for the third quarter of fiscal year 2024, which ended June 30, 2024, and issued its out...

Ashland sets date for fiscal 2024 third-quarter earnings release and conference call webcast
WILMINGTON, Del., July 17, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its third-quarter earnings release at approximately 5 p.m. ET on Tuesday, August 6, 2024. Th...

Ashland achieves certification by Fair Wage Network
WILMINGTON, Del., June 18, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) has strengthened its performance towards environmental, social and governance (ESG) practices and a more just and equitable...

Ashland Board appoints Ashish K. Kulkarni as new director
WILMINGTON, Del., May 08, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) is announcing the appointment of Ashish K. Kulkarni to its Board of Directors. Kulkarni is the CEO of Kebotix, a startup com...

Turnspire Capital Partners to Acquire Ashland Nutraceuticals Business
NEW YORK--(BUSINESS WIRE)--Turnspire Capital Partners LLC (“Turnspire”) announced today that an affiliate has signed a definitive agreement to acquire the nutraceuticals business of Ashland Inc. (NYSE...